Weight loss September 18, 2024 HCG vs Ozempic: Which is Best Weight Loss Option for You
Semaglutide Clinical Data The STEP trial program represents the most comprehensive clinical evaluation of any GLP-1 receptor agonist for weight management: STEP 1: 14.9% mean body weight loss over 68 weeks (Wilding et al., NEJM , 2021) STEP 3: 16.0% with intensive behavioral therapy over 68 weeks STEP 5: Sustained 15.2% weight loss maintained at 104 weeks with continued treatment SELECT trial: Demonstrated 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in addition to weight loss, establishing cardiovascular benefit (Lincoff et al., NEJM , 2023) The SELECT trial result is particularly significant because it demonstrated that semaglutide provides cardiovascular protection independent of weight loss, a benefit that has not been established for tesofensine
12.2 Pharmacodynamics Semaglutide lowers fasting and postprandial blood glucose and reduces body weight
Documentation Requirements Accurate and comprehensive documentation is crucial for obtaining insurance coverage
Sometimes when I'm doing a facelift, I'm taking out inches of skin [to correct sagging]